Last update: April 1, 2019

Glycophosphopeptical

Very Low Risk for breastfeeding


Compatible.
Not risky for breastfeeding or infant.

An association of a polysaccharide (glucomannan) obtained from Candida utilis and a protein rich in glutamine obtained from ungerminated seeds of Ricinus communis on an inorganic matrix of calcium sulphate and phosphate.
Oral administration 3 times a day.

Since the last update we have not found any published data on its excretion in breast milk.

Its high molecular weight makes transfer into breastmilk in significant quantities unlikely.

Due to its protein and glucidic nature it is digested in the intestine, so it has a low oral bioavailability (CECMED 2015), which hinders passage to infant plasma from breastmilk.

It has no side effects.
Its efficacy as an immunomodulator is not proven (Murciasalud 2006).
The literature on this drug is scarce and/or out-of-date, and it is sold in few countries.
It has zero or low therapeutic utility, and is totally non-essential.

Alternatives

We do not have alternatives for Glycophosphopeptical since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Glycophosphopeptical is also known as


Glycophosphopeptical in other languages or writings:

Group

Glycophosphopeptical belongs to this group or family:

Tradenames

Main tradenames from several countries containing Glycophosphopeptical in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability 5 %
Molecular weight > 160.000 daltons

References

  1. CECMED. Inmunoferon. Ficha técnica. 2015 Full text (in our servers)
  2. Murciasalud. ¿Existe evidencia que recomiende el uso de Polypodium Leucotomos o de glicofosfopeptical en el tratamiento preventivo de las infecciones respiratorias de las vías altas recurrentes? Banco de Preguntas Preevid. 2006 Full text (link to original source) Full text (in our servers)

Total visits

3,863

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM